CompaniesByCap
MBRX
Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare

Moleculin Biotech Inc. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-22.7M-23.9M-23.6M-27.6M-19.0M-17.8M-17.2M-12.2M-7.3M-3.8M
Depreciation & Amort.90,000126,000127,000130,000164,000200,000199,00068,00018,0006,000
Investing Activities
Capital Expenditure013,000124,00067,00019,000376,00052,000417,00028,00021,000
Free Cash Flow-22.7M-23.9M-23.7M-27.7M-19.0M-18.1M-17.3M-12.6M-7.4M-3.8M
Financing Activities
Dividends Paid
Stock Buybacks

Moleculin Biotech Inc. Cash Flow — FAQ

Moleculin Biotech Inc. (MBRX) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MBRX's cash flow history?

The chart and table above show Moleculin Biotech Inc.'s cash flow by year and by quarter, including the growth rate.